Free tool
FAERS Monitor: Potassium Acetate
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018896 or its brand name (Potassium Acetate, Potassium Acetate). Reports on generic versions are filed under their own applications.
Reports
1,458
Serious
1,056
72% of reports
Hospitalization
561
Death reported
160
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea109
- diarrhoea108
- nausea108
- fatigue103
- asthenia85
- dizziness84
- drug ineffective84
- headache61
- weight decreased60
- death57
- pain57
- vomiting57
- fall54
- pneumonia54
- pyrexia52
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 8 |
| 2005 | 90 |
| 2006 | 242 |
| 2007 | 424 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 75 |
| 2012 | 96 |
| 2013 | 12 |
| 2014 | 8 |
| 2015 | 17 |
| 2016 | 39 |
| 2017 | 31 |
| 2018 | 56 |
| 2019 | 62 |
| 2020 | 55 |
| 2021 | 34 |
| 2022 | 38 |
| 2023 | 26 |
| 2024 | 42 |
| 2025 | 34 |
| 2026 | 59 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,701 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| astheniaSignal | 85 | 3.3 | 2.7 | 133 |
| weight decreasedSignal | 60 | 3.1 | 2.4 | 84 |
| dyspnoeaSignal | 109 | 2.8 | 2.3 | 126 |
| dizzinessSignal | 84 | 2.4 | 2.0 | 71 |
| diarrhoeaSignal | 108 | 2.4 | 2.0 | 91 |
| pneumoniaSignal | 54 | 2.4 | 1.9 | 44 |
| fallSignal | 54 | 2.3 | 1.8 | 41 |
| pyrexiaSignal | 52 | 2.2 | 1.7 | 32 |
| nausea | 108 | 2.0 | 1.6 | 52 |
| fatigue | 103 | 1.9 | 1.6 | 45 |
| vomiting | 57 | 1.7 | 1.4 | 18 |
| headache | 61 | 1.4 | 1.1 | 7 |
| pain | 57 | 1.3 | 1.0 | 5 |
| death | 57 | 1.0 | 0.7 | 0 |
| drug ineffective | 84 | 0.9 | 0.7 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.